Update Report on Intraocular Lenses

Worthen, David M.; Boucher, James A.; Buxton, Jorge N.; Lowther, Gerald E.; Talbott, Max W.

doi:10.1016/s0161-6420(81)35014-3

Cited by 9 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In several other reviews from this time period, however, keratoconus was a leading indication for penetrating keratoplasty, and it incidence was noted to be rising by the close of the decade [5][6][7].…”

Section: -1990mentioning

confidence: 97%

See 1 more Smart Citation

Trends in penetrating keratoplasty in the United States 1980–2005

et al. 2007

View full text Add to dashboard Cite

In this review, we analyze the trends in corneal transplantation over the past 25 years in the United States. The most dramatic change was the progressive sharp increase in the number of corneal transplants performed during the 1980s, corresponding with the rise of pseudophakic bullous keratopathy (PBK) as the leading indication for keratoplasty. More recently, there has been a steady annual decline in total keratoplasties for more than a decade, corresponding with a decline in the cases performed for PBK, which still accounts for the highest percentage of cases done. Regrafts have been an increasingly important indication for keratoplasty, as older grafts fail. Keratoconus, Fuchs dystrophy, and other inherited diseases have remained consistent indications for keratoplasty during the last quarter century.

show abstract

Section: -1990mentioning

confidence: 97%

“…Prior to 1980, most surgeons had been trained to leave patients aphakic. Only 177,000 lenses of four different classes were implanted in 1979 [7]; in contrast, in 1983 alone, 409,000 intraocular lenses were implanted [8]. As the new lenses became more in vogue and patient outcomes improved, the drive to place intraocular lenses grew.…”

Section: -1990mentioning

confidence: 99%

Trends in penetrating keratoplasty in the United States 1980–2005

et al. 2007

View full text Add to dashboard Cite

show abstract

“…In February 1978, national studies of IOLs were begun under investigational device exemption (IDES), approved by the FDA, to determine the safety and effectiveness of the IOL as a medical device for the correction of aphakia. 1- 3 The purpose of this report is to present information on the numbers, the types, and the current usage trends of the IOLs being implanted in the United States, and to provide data on those lenses that have been reviewed by the Ophthalmic Device Section of the FDA Ophthalmic; Ear, Nose, Throat; and Dental Devices Panel of the Office of Medical Devices, and have been recommended for premarket approval as being safe and effective. approved IDE.…”

mentioning

confidence: 99%

The Fda Report on Intraocular Lenses*

Stark

Worthen

Holladay

et al. 1984

Australian Journal of Opthalmology

View full text Add to dashboard Cite

Clinical studies of intraocular lenses (IOLs) as investigational devices have been regulated in the United States by the Food and Drug Administration (FDA) since 9 February 1978. As of August 1982. data have been collected on more than one million IOLs implanted. During the last 12 months of the study, 409 000 IOLs were implanted. Visual acuity of 20/40 or better at one year after surgery was present in 85% of over 45 000 cases reviewed. Increasing patient age, surgical problems, postoperative complications, and adverse reactions were factors that reduced the visual acuity. The current trend in the USA is for implantation of posterior chamber and anterior chamber IOLs.

show abstract

Cataracts and Cataract Operations (First of Two Parts)

Liesegang¹

1984

Mayo Clinic Proceedings

View full text Add to dashboard Cite

Update Report on Intraocular Lenses

Cited by 9 publications

References 1 publication

Trends in penetrating keratoplasty in the United States 1980–2005

Trends in penetrating keratoplasty in the United States 1980–2005

The Fda Report on Intraocular Lenses*

Cataracts and Cataract Operations (First of Two Parts)

Contact Info

Product

Resources

About